PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,386,000 | +11.1% | 307,547 | +2.1% | 0.00% | 0.0% |
| Q1 2020 | $2,147,000 | -70.0% | 301,175 | +0.6% | 0.00% | -66.7% |
| Q4 2019 | $7,149,000 | -11.9% | 299,391 | -1.0% | 0.00% | 0.0% |
| Q3 2019 | $8,113,000 | +16.9% | 302,501 | +18.2% | 0.00% | 0.0% |
| Q2 2019 | $6,941,000 | +1080.4% | 255,839 | +2018.0% | 0.00% | -25.0% |
| Q4 2017 | $588,000 | – | 12,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,220,672 | $52,025,000 | 8.00% |
| Fernwood Investment Management, LLC | 190,011 | $8,098,000 | 7.10% |
| Cormorant Asset Management, LP | 500,000 | $21,310,000 | 3.40% |
| HARVEY CAPITAL MANAGEMENT INC | 157,930 | $6,730,000 | 2.69% |
| Atika Capital Management LLC | 128,000 | $5,456,000 | 2.68% |
| Redmile Group, LLC | 769,641 | $32,802,000 | 2.48% |
| Temasek Holdings (Private) Ltd | 5,833,568 | $248,627,000 | 2.36% |
| SECTORAL ASSET MANAGEMENT INC | 1,088,118 | $46,376,000 | 2.12% |
| Eventide Asset Management | 479,900 | $20,453,000 | 1.19% |
| BBT Capital Management, LLC | 200,000 | $8,524,000 | 0.79% |